The Evolution of Early-phase Research
From startups to major research organizations, early-phase research can be managed in different ways depending on the company.
Colleen Hoke, Co-Founder and CEO of ObjectiveHealth discusses her career in early-phase research and the transition from working with a startup to a major research organization. She also touches on what her current company, ObjectiveHealth is working on, leadership skills, and the evolution of clinical research.
About the speaker
Having held leadership and executive positions at clinical research organizations, specialty providers, and healthcare entities, Colleen has more than 25 years of experience in the areas of business development, organizational management, and executive team building. She was a key member of an executive team that built a successful early-phase research site that was later acquired by a major research corporation, and she has contributed to best practice standards for the Association of Clinical Pharmacology Units (ACPU). Colleen holds a bachelor’s degree of science from the University of Tennessee and is a graduate of the Wharton School of Business Executive Leadership course.
About the ACT Podcast
The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
